LivaNova outlines 6%–7% revenue growth for 2026 as core businesses expand and OSA launch nears [Seeking Alpha]
LivaNova PLC - Ordinary Shares (LIVN)
Last livanova plc - ordinary shares earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
livanova.com
Company Research
Source: Seeking Alpha
We delivered double-digit revenue growth, meaningful adjusted operating margin expansion and robust cash generation, reflecting strong execution across our cardiopulmonary Quick Insights LivaNova's key growth drivers for 2026 are ongoing strength in cardiopulmonary and epilepsy businesses, new product launches, entry into the obstructive sleep apnea (OSA) market, and reimbursement improvements. Main risks include supply chain constraints, moderation in price premiums, and slow penetration rates in new markets. LivaNova expects to sustain margin and revenue growth through conservative guidance assumptions, operational execution, supply chain risk mitigation, new leadership for OSA commercialization, maintained R&D in core businesses, and increased investment in OSA. The outlook includes 6–7% revenue growth and a 20–21% adjusted operating income margin. Improved reimbursement is expected to accelerate epilepsy device penetration, with significant positive impact on both new and
Show less
Read more
Impact Snapshot
Event Time:
LIVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIVN alerts
High impacting LivaNova PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LIVN
News
- Annals of Internal Medicine Publishes 12-Month Results from LivaNova's OSPREY Clinical Study for Obstructive Sleep Apnea [Yahoo! Finance]Yahoo! Finance
- Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep ApneaBusiness Wire
- Should FDA Approval of aura6000 Sleep Apnea Therapy Require Action From LivaNova (LIVN) Investors? [Yahoo! Finance]Yahoo! Finance
- LivaNova to Announce First-Quarter 2026 ResultsBusiness Wire
- LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep ApneaBusiness Wire
LIVN
Earnings
- 2/25/26 - Beat
LIVN
Sec Filings
- 4/1/26 - Form 4
- 4/1/26 - Form 4
- 4/1/26 - Form 4
- LIVN's page on the SEC website